ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,569.90
-1.23%
S&P ASX All Technology
2,968.80
-1.53%
Brent Oil
85.055
-0.98%
US Dollar vs AUD
1.54309
-0.07%
Bitcoin
57,631.58
-4.90%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Exscientia PLC (EXAI)

  7. Exscientia PLC (EXAI) News

EXAI

Exscientia (EXAI)

Exscientia PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EXAI
DateTimeSourceHeadlineSymbolCompany
21/03/202422:26IH Market NewsU.S. Index Futures Rise as Fed’s Dovish Outlook Spurs Positive Investor Sentiment; Oil Prices See Minor DeclinesNASDAQ:EXAIExscientia PLC
21/03/202422:00Business WireExscientia Business and Financial Update for the Full Year 2023NASDAQ:EXAIExscientia PLC
15/03/202402:29Business WireExscientia présentera ses résultats financiers pour l’année 2023 le 21 mars 2024NASDAQ:EXAIExscientia PLC
15/03/202402:29Business WireExscientia berichtet am 21. März 2024 über die Finanzergebnisse für das Gesamtjahr 2023NASDAQ:EXAIExscientia PLC
14/03/202422:00Business WireExscientia to Report Full Year 2023 Financial Results on March 21, 2024NASDAQ:EXAIExscientia PLC
01/03/202400:20Business WireExscientia präsentiert auf kommenden Investorenkonferenzen im MärzNASDAQ:EXAIExscientia PLC
29/02/202401:08Business WireExscientia participera à de prochaines conférences d'investisseurs au mois de marsNASDAQ:EXAIExscientia PLC
28/02/202423:00Business WireExscientia to Present at Upcoming Investor Conferences in MarchNASDAQ:EXAIExscientia PLC
13/02/202422:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
13/02/202403:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EXAIExscientia PLC
08/02/202405:45Business WireExscientia startet klinische Studie zur weiteren Evaluierung der Plattform für funktionelle Präzisionsmedizin bei KrebspatientenNASDAQ:EXAIExscientia PLC
08/02/202405:45Business WireExscientia lance une étude clinique pour approfondir l'évaluation de la plateforme de médecine de précision fonctionnelle chez les patients atteints de cancerNASDAQ:EXAIExscientia PLC
07/02/202423:00Business WireExscientia Initiates Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer PatientsNASDAQ:EXAIExscientia PLC
09/01/202408:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXAIExscientia PLC
03/01/202402:36Business WireLe professeur Andrew L. Hopkins est nommé Commandeur de l'Ordre de l'Empire britannique (CBE)NASDAQ:EXAIExscientia PLC
03/01/202402:28Business WireProfessor Andrew L. Hopkins zum Commander of the Order of the British Empire (CBE) ernanntNASDAQ:EXAIExscientia PLC
02/01/202423:00Business WireProfessor Andrew L. Hopkins appointed Commander of the Order of the British Empire (CBE)NASDAQ:EXAIExscientia PLC
22/12/202305:09Business WireExscientia annonce une extension de sa collaboration actuelle avec Sanofi en vue d’inclure le programme existant d’ExscientiaNASDAQ:EXAIExscientia PLC
22/12/202301:45Business WireExscientia gibt die Ausweitung der aktuellen Zusammenarbeit mit Sanofi auf das bestehende Exscientia-Programm bekanntNASDAQ:EXAIExscientia PLC
21/12/202323:00Business WireExscientia Announces Expansion of its Current Collaboration with Sanofi to Include Existing Exscientia ProgrammeNASDAQ:EXAIExscientia PLC
06/12/202305:54Business WireExscientia reçoit une subvention d’Open Philanthropy pour explorer une nouvelle approche thérapeutique de la grippe pandémiqueNASDAQ:EXAIExscientia PLC
06/12/202304:11Business WireExscientia erhält Zuschüsse von Open Philanthropy zur Erforschung eines neuen therapeutischen Ansatzes für pandemische InfluenzaNASDAQ:EXAIExscientia PLC
05/12/202323:00Business WireExscientia Receives Open Philanthropy Grant to Explore New Therapeutic Approach for Pandemic InfluenzaNASDAQ:EXAIExscientia PLC
22/11/202306:26Business WireExscientia präsentiert sich auf der 6. Jahreskonferenz HealthCONx von Evercore ISINASDAQ:EXAIExscientia PLC
22/11/202303:52Business WireExscientia participera à la 6e conférence annuelle Evercore ISI HealthCONxNASDAQ:EXAIExscientia PLC
21/11/202323:00Business WireExscientia to Present at the 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:EXAIExscientia PLC
09/11/202323:58Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
09/11/202323:00Business WireExscientia Business Update for Third Quarter 2023NASDAQ:EXAIExscientia PLC
03/11/202303:36Business WireExscientia publiera ses résultats financiers du troisième trimestre 2023 le 9 novembre 2023NASDAQ:EXAIExscientia PLC
03/11/202303:36Business WireExscientia meldet am 9. November 2023 Finanzergebnisse für drittes Quartal 2023NASDAQ:EXAIExscientia PLC
 Showing the most relevant articles for your search:NASDAQ:EXAI

Your Recent History

NYSE
XOM
Exxon Mobil
NYSE
VZ
Verizon Communications
ASX
FMG
Fortescue
NASDAQ
AAPL
Apple
ASX
NAB
National Australia Bank
ASX
XJO
S&P ASX 200
FX
EURAUD
Euro vs AUD
ASX
WDC
Westfield
NASDAQ
GOOGL
Alphabet
COIN
ETHUSD
Ethereum
ASX
AMP
AMP
ASX
XFL
S&P ASX 50
ASX
QBE
QBE Insurance
ASX
WOW
Woolworths
ASX
BHP
BHP
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved